Human Metapneumovirus (HMPV): The Overlooked Respiratory Virus Affecting All Ages”

Human Metapneumovirus, or HMPV, is a viral respiratory infection that targets young children, older people, and patients with compromised immunity. It’s a frequent cause of respiratory illnesses resembling RSV (Respiratory Syncytial Virus).

Symptoms:

Most symptoms resemble a cold or mild flu, but can be more severe in vulnerable groups:

• Cough
• Runny nose
• Sore throat
• Fever
• Wheezing
• Shortness of breath

Who Is at Risk?

While HMPV can infect individuals of all ages, certain groups are more susceptible to severe illness:​

• Infants and young children
• Adults over 65 years
• People with weakened immune systems
• Individuals with underlying respiratory conditions​

Most people are exposed to HMPV during childhood, with infections commonly occurring in late winter and early spring.​

Diagnosis

Diagnosis of HMPV is typically confirmed through laboratory tests, such as polymerase chain reaction (PCR) assays, which detect viral RNA in respiratory specimens. However, due to overlapping symptoms with other respiratory viruses, HMPV is often underdiagnosed.​

Treatment and Recovery

There is currently no specific antiviral treatment for HMPV. Management focuses on supportive care:​

• Rest
• Hydration
• Over-the-counter medications to alleviate symptoms (e.g., acetaminophen for fever)​

Most individuals recover within 7 to 10 days. However, those with severe symptoms, especially in high-risk groups, may require hospitalization and supportive therapies .

Prevention

Preventative measures are crucial in reducing the spread of HMPV:​

• Regular handwashing with soap and water
• Avoiding close contact with sick individuals
• Disinfecting frequently touched surfaces
• Staying home when exhibiting symptoms of illness

Global Impact

Recent studies have highlighted the significant burden of HMPV on global health, particularly among children under five years of age. The virus contributes to a notable percentage of hospitalizations due to acute respiratory infections worldwide.​

Recent Developments

In early 2025, northern China experienced a surge in HMPV cases, leading to increased public health surveillance. Experts attribute this rise to enhanced detection methods and decreased population immunity following COVID-19 restrictions. Despite the uptick, health authorities have noted that the situation is under control, with no significant strain on healthcare resources.